about
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience...
Read More
4.62
0.10
(2.21%)
862.4K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Inventiva (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..